Please provide your email address to receive an email when new articles are posted on . Tenecteplase, a fibrin-specific recombinant tissue plasminogen activator, was safe and effective for the ...
PURPOSE: To evaluate the safety and efficacy of alteplase (TPA) for restoring function to occluded central venous catheters (CVCs). PATIENTS AND METHODS: The study design was a phase III, open-label, ...
Controlling pain using a femoral nerve catheter rather than standard intravenous opioids may improve early knee function after total knee arthroplasty, a study suggests. Martin L. De Ruyter, MD, ...
Before 1998, urokinase was considered standard therapy for the management of occluded hemodialysis catheters. The dose of 5000 units per port appears on the FDA-approved labeling for urokinase. Bolus ...
In advanced clinical practice, up to 4/5th of the hospitalized patients require intravenous therapy at some point during their hospital stay. This intravenous route can involve administering ...
Medical Device Network on MSN
Abbott’s dual ablation catheter lands FDA approval
FDA clearance for Abbott’s TactiFlex Duo follows the dual ablation catheter’s receipt of a European CE mark in January 2026.
LONDON (MarketWatch) -- Nuvelo Inc. said that Phase 2 clinical trial results shows that alfimeprase can quickly restore function to occluded central venous access devices. The results demonstrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results